Circulating Tumor Material in Colorectal Cancer and Melanoma

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

7 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-07-07

Study Completion Date

2020-07-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Observational study to allow the collection of blood and medical information to evaluate the role of circulating tumor material in patients with colorectal cancer and melanoma

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

SLN in Colon Cancer Using a Multimodal Tracer

NCT02850783

Sentinel Lymph Node

COMPLETED PHASE2/PHASE3

Expanded Access Study of TAS-102 in Patients With Metastatic Colorectal Cancer

NCT02286492

Colorectal Cancer Metastatic

APPROVED_FOR_MARKETING

Epidemiological Study to Monitor Study Participants With Resected Stage II (High Risk) or Stage III Colorectal Cancer for Circulating Tumor DNA Before, During and After Their Treatment With Adjuvant Chemotherapy

NCT04813627

Colorectal Cancer Stage II Colorectal Cancer Stage III

ACTIVE_NOT_RECRUITING

Study of Biomarkers in Patients Undergoing Chemotherapy for Metastatic Colorectal Cancer

NCT00559676

Colorectal Cancer

COMPLETED PHASE4

Phase II Trial of Abraxane and Capecitabine in Metastatic Colon Cancer (COL 01)

NCT00625573

Colorectal Cancer

COMPLETED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Colorectal Cancer and Melanoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

colorectal cancer

blood collection

Intervention Type OTHER

Patients will receive a research draw for circulating tumor material analysis with standard clinical labs

melanoma

blood collection

Intervention Type OTHER

Patients will receive a research draw for circulating tumor material analysis with standard clinical labs

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

blood collection

Patients will receive a research draw for circulating tumor material analysis with standard clinical labs

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* The subject must be a patient at the Hospital of the University of Pennsylvania

1. Patients with presumed stage II, III, or IV colorectal cancer with planned surgical resection of either the primary tumor or metastatic lesion(s) being evaluated at the Hospital of the University of Pennsylvania
2. Patients with histologically confirmed melanoma stage IIb, IIc, IIIa, IIIb, or IIIc/IV scheduled for surgical resection being evaluated at the Hospital of the University of Pennsylvania.
* The subject must be able to provide informed consent or have an acceptable surrogate capable of giving consent on the subject's behalf.
* The subject must be 18 years of age or older.